Q99538 (LGMN_HUMAN) Homo sapiens (Human)
Legumain UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human legumain in complex with Clitocypin 2 |
Heteromer Q3Y9I4; | 1×NAG; 2×NAG; | ||||
| Assess | ||||||
| Crystal structure of reduced legumain in complex with cystatin E/M |
Heteromer Q15828; | 1×NAG; 1×NAG; 5×IOD; | ||||
| Assess | ||||||
| Crystal structure of oxidized legumain in complex with cystatin E/M |
Heteromer Q15828; | 1×NAG; 1×NAG; 5×IOD; | ||||
| Assess | ||||||
| Crystal structure of human legumain in complex with macrocypin 1a |
Heteromer B9V973; | 2×NAG; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of active legumain in complex with AAN-CMK | homo-2-mer | 6×NAG; 2×SO4; 4×HG; | ||||
| Assess | ||||||
| Crystal structure of prolegumain | monomer | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-… | monomer | 1×NAG; 1×WSN; 3×EDO; | ||||
| Assess | ||||||
| Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-… | monomer | 1×NAG; 1×WSN; 1×EDO; 1×PG4; 1×EPE; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B | monomer | 2×SO4; 2×NAG; 1×EMC; 1×5KN; | ||||
| Assess | ||||||
| Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-1-(1,3-oxazol-2-yl)-5-oxop… | monomer | 1×EDO; 1×WS9; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of active legumain in complex with YVAD-CMK | monomer | 3×NAG; 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of YVAD-cmk bound human legumain (AEP) in complex with compound 11 | monomer | 2×NAG; 2×SO4; 1×3Y7; | ||||
| Assess | ||||||
| Crystal structure of active legumain in complex with YVAD-CMK at pH 5.0 | monomer | 2×SO4; 3×NAG; | ||||
| Assess | ||||||
| Crystal structure of human legumain in complex with Gly-Ser-Asn peptide | monomer | 2×NAG; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of human legumain (AEP) in complex with compound 11b | monomer | 2×NAG; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of human legumain (AEP) in complex with compound 11 | monomer | 2×NAG; 1×NAG; | ||||
| Assess | ||||||
| Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-… | monomer | 1×WR9; 1×EDO; 1×NAG; | ||||
| Assess | ||||||
| Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-… | monomer | 1×WSN; 1×NAG; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4nok.1.A | monomer | 0.89 | 83.14 | |||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4nok.1.A | monomer | 0.88 | 84.84 | ||
| Assess | ||||||
| Isoform 3 | 4nok.1.A | monomer | 0.90 | 85.39 | ||
| Assess | ||||||